Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Anchalee Avihingsanon | Pharmaceutical Policy and Regulation | Best Researcher Award

Dr. Anchalee Avihingsanon, HIV-NAT, Thai Red Cross AIDS and Infectious Diseases Research Collaboration, Thailand

Dr. Anchalee Avihingsanon, MD, PhD 🩺🔬 is a distinguished infectious disease specialist with over 20 years of expertise in HIV/AIDS, tuberculosis, and viral hepatitis research. She leads the HIV-NAT clinical research program at the Thai Red Cross AIDS and Infectious Disease Research Centre in Bangkok 🇹🇭 and serves as Clinical Research Site Leader for ACTG. Dr. Avihingsanon actively shapes national health policies in Thailand and contributes to WHO guideline development 🌏. Her international research spans clinical trials addressing HIV, TB, and emerging infections. She has earned numerous awards for her impactful work in resource-limited settings.

Publication Profile

Orcid

Education

Dr. Anchalee Avihingsanon completed her medical degree (MD) at Khon Kaen University, Thailand, from 1986 to 1992. She then specialized in Internal Medicine at Chulalongkorn University, Bangkok, during 1994-1996, followed by a focus on Infectious Disease from 1998 to 1999 at the same institution. Dr. Avihingsanon advanced her expertise as a research fellow in Infectious Diseases at Beth Israel Deaconess Medical Center in Boston, USA, from 2000 to 2002. She earned her PhD in HIV and Coinfection at Amsterdam University, The Netherlands, between 2011 and 2013.

Experience

Dr. Anchalee Avihingsanon has been actively involved in numerous professional roles since 1999. She currently serves as the ACTG Regional Representative for Asia and is a key member of several WHO advisory groups on HIV, viral hepatitis, and STIs. She is also an infectious disease expert on Bangkok’s Essential Medicine Committee and contributes to national efforts on AIDS, TB, and hepatitis. Dr. Avihingsanon participates in multiple research and guideline committees, including the Thai Ministry of Public Health and international scientific groups. She holds memberships in prestigious organizations like the International AIDS Society and the Royal College of Physicians.

Awards

Dr. Anchalee Avihingsanon has received numerous honors throughout her career. In 2016, she successfully passed the US-FDA inspection for key studies. She was awarded the Australia-APEC Women in Research Fellowship in 2015 and received the prestigious NUFFIC PhD grant from the Netherlands Embassy during 2011-2013. Dr. Avihingsanon earned scholarships to attend global workshops and conferences, including the European AIDS Conference and International AIDS Society from 2007 to 2022. Early in her career, she was recognized as Best Doctor at Samutsakorn Hospital in 1998 and served as chief resident at King Chulalongkorn Memorial Hospital in 1997.

Research Focus

Dr. Anchalee Avihingsanon is a distinguished researcher specializing in HIV and Hepatitis C co-infections, with a strong focus on antiretroviral therapy optimization, pharmacokinetics, and treatment outcomes. Her work includes evaluating minimal monitoring HCV treatments, assessing drug interactions in people living with HIV, and improving health-related quality of life for patients. She also investigates malnutrition, sarcopenia risks in elderly HIV patients, and liver fibrosis progression using advanced diagnostics. Anchalee’s contributions significantly impact infectious disease management, particularly in Asian populations, aiming to enhance therapy safety, efficacy, and accessibility.

Publication Top Notes

Impact of a minimal monitoring HCV treatment approach on Health-Related Quality of Life
The population pharmacokinetics of dolutegravir co‐administered with rifampicin in Thai people living with HIV: Assessment of alternative dosing regimens
Performance of Elecsys® HCV Duo Immunoassay for Diagnosis and Assessment of Treatment Response in HCV Patients with or without HIV Infection
The Risk of Malnutrition and Sarcopenia in Elderly People Living with HIV during the COVID-19 Pandemic
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection
Efficacy and safety of switching to bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed Asian adults living with HIV: A pooled analysis from three international phase III randomized trials
The 25th Bangkok International Symposium on HIV Medicine
Dose optimization with population pharmacokinetics of ritonavir-boosted lopinavir for Thai people living with HIV with and without active tuberculosis
Conference Proceedings from the Virtual 24th Bangkok International Symposium on HIV Medicine
Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial

H.G. Parsa | Regulatory Affairs | Best Researcher Award

H.G. Parsa | Regulatory Affairs | Best Researcher Award

Dr H.G. Parsa, University of Denver, United States

Dr. H.G. Parsa is a distinguished scholar in hospitality and business management, with a Ph.D. from Virginia Tech. He has held prominent positions, including Barron Hilton Chair in Lodging at the University of Denver. His research spans corporate social responsibility, sustainability, revenue management, and entrepreneurship. Dr. Parsa has earned multiple awards, including the Hospitality Educator of the Year in Ohio and served as a keynote speaker globally. He is a visiting professor at prestigious institutions worldwide. His expertise is sought by top organizations like Marriott and McDonald’s. He’s also an advisory board member for the Hispanic Restaurant Association. 🌍📚🏨🍴

Publication Profile

Scopus

Education

Dr. H.G. Parsa holds a Ph.D. from Virginia Tech, where he won the International Franchise Association Research Competition for his dissertation on “Exploratory Investigation of Organization Power, and Its Impact on Strategy Implementation and Firm Performance in Hospitality Franchise Systems.” He earned his M.S. from the University of Arkansas and M.Sc. and B.Sc. (Honors) from Osmania University, India. Dr. Parsa also completed Business Management coursework at the University of Central Oklahoma. His research is guided by esteemed advisors, including Dr. Mahmood A. Khan and Dr. James R. Brown. 📚🏆🎓

International Recognition

Dr. H.G. Parsa is an internationally recognized expert in hospitality education and research, with a global impact reflected in his teaching appointments and collaborations across various countries. His extensive experience includes visiting professorships in France 🇫🇷, Vietnam 🇻🇳, India 🇮🇳, and many more, contributing to the development of hospitality programs worldwide. Dr. Parsa’s research focuses on advancing the field through cross-cultural perspectives and innovative educational strategies. His global presence and commitment to enhancing hospitality education have earned him recognition as a leading figure in the academic community 🌍🎓. His work continues to shape the future of hospitality studies.

Awards and Honors

Dr. H.G. Parsa is widely recognized as a leading expert in his field, having been nominated for prestigious awards such as the Willie McCool Breakthrough Award. He was also a finalist for the Fulbright and Nehru-Fulbright Distinguished Chair Awards, highlighting his significant contributions to academia. In addition to these accolades, Dr. Parsa has been invited as a keynote speaker at several international conferences, showcasing his expertise and global recognition. These achievements reflect his dedication and impact, positioning him as a respected figure in his professional community. 🏅🌍🎤📚

Experience 

Dr. H.G. Parsa is a distinguished academic and visiting professor with extensive international experience. He has held teaching roles at renowned institutions such as Vin University (Vietnam), Institut Paul Bocuse (France), University of Southern California (USA), and several universities across India, Taiwan, and Europe. Currently, Dr. Parsa serves as the Barron Hilton Chair in Lodging & Professor at the University of Denver’s Fritz Knoebel School of Hospitality Management. He is also an Associate Editor for prestigious journals like the Journal of Hospitality and Tourism Research and Cornell Hospitality Management. 🌍📚🍴✈️🎓

Research Contribution

Dr. H.G. Parsa’s research focuses on key areas of business and hospitality, including Corporate Social Responsibility (CSR), green practices, and sustainability 🌱. His work also explores revenue management, pricing strategies, and revenue analytics in hospitality 🍽️📊. Additionally, he delves into the entrepreneurship of restaurant ventures, analyzing macro and micro factors contributing to restaurant failures 🍴💡. His studies extend to consumer behavior, exploring restaurant attributes and their influence on willingness to pay and patronize 🏷️🍔. Dr. Parsa is also interested in marketing strategies, branding, franchising, and tracking changing American food habits 🍔📉.

Presentations

Dr. H.G. Parsa has contributed extensively to hospitality and tourism research. His award-winning case studies include Swachh Bharath Campaign and the Indian Tourism Industry (2019), and Hospitality with a Heart and Soul (2014), which won the Best Case Research Award. He has also co-authored impactful works, such as Chipotle Mexican Grill: A Sustainability Champion Going Global with China (2018). Dr. Parsa has presented at prominent conferences, including the Euro CHIRE and Revenue Management Conferences, addressing topics like restaurant revenue performance, classification frameworks, and the impact of CSR on consumer behavior. 🌍🏆🍽️📚

Publication Top Notes

Hedonic and utilitarian motivations and the role of trust in using food delivery apps: an investigation from a developing economy

Hotels and shared economy accommodations: an analysis of business traveler preferences

The Criticality of Public Policy in Hospitality and Tourism Research

Airbnb and Business Travelers: A Prospect Theory Explanation

Why Restaurants Fail? Part V: Role of Economic Factors, Risk, Density, Location, Cuisine, Health Code Violations and GIS Factors

New Classification System for the U.S. Restaurant Industry: Application of Utilitarian and Hedonic Continuum Model